Lambros Kordelas
Ratingen, NW, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 41 publications
Molecular characterization of CD36 deficiency in blood donors of Middle Eastern and African origin reveals transcript-level defects beyond genomic variants.
Journal: Transfusion
Published: July 07, 2026
Treatment sequence with gilteritinib and allogeneic haematopoietic stem cell transplantation in relapsed/refractory FMS-like tyrosine kinase 3 (FLT3)-mutated acute myeloid leukaemia patients: A multicentre real-world study.
Journal: British journal of haematology
Published: March 04, 2026
Endothelial Activation and Stress Index (EASIX) to predict mortality after allogeneic stem cell transplantation: a prospective study.
Journal: Journal for immunotherapy of cancer
Published: December 18, 2023
Recruiting refugees and migrants as potential hematopoietic stem cell donors to serve patients of comparable ethnicities with rare human leucocyte antigen patterns - The BluStar.NRW project in North Western Germany.
Journal: Transplant immunology
Published: September 15, 2023
Peripheral HLA-G/ILT-2 immune checkpoint axis in acute and convalescent COVID-19 patients.
Journal: Human immunology
Published: January 15, 2023
Independent human mesenchymal stromal cell-derived extracellular vesicle preparations differentially attenuate symptoms in an advanced murine graft-versus-host disease model.
Journal: Cytotherapy
Published: November 19, 2022
EASIX-1year and late mortality after allogeneic stem cell transplantation.
Journal: Blood advances
Published: July 21, 2022
Pre-Transplant Serum Leptin Levels and Relapse of Acute Myeloid Leukemia after Allogeneic Transplantation.
Journal: International journal of molecular sciences
Published: January 22, 2022
Editorial: "The Role of Immune Checkpoint Molecules in Solid and Hematopoietic Stem Cell Transplantation".
Journal: Frontiers in immunology
Published: November 25, 2021
Correction to: Treatment of myeloid malignancies relapsing after allogeneic hematopoietic stem cell transplantation with venetoclax and hypomethylating agents-a retrospective multicenter analysis on behalf of the German Cooperative Transplant Study Group.
Journal: Annals of hematology
Published: June 23, 2021
Low Soluble Programmed Cell Death Protein 1 Levels After Allogeneic Stem Cell Transplantation Predict Moderate or Severe Chronic GvHD and Inferior Overall Survival.
Journal: Frontiers in immunology
Published: April 13, 2021
Last Updated: 09/26/2026